Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

245.00p
   
  • Change Today:
      16.50p
  • 52 Week High: 470.00p
  • 52 Week Low: 166.80p
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 189,306
  • Market Cap: £245.00m
  • RiskGrade: 125

ShareCast News

Oxford Biomedica strikes three-year deal with Bo... 06-Apr-2021 ShareCast
Oxford Biomedica says Sanofi pulling out of haem... 19-Mar-2021 ShareCast
Oxford Biomedica strikes collaboration agreement... 09-Nov-2020 ShareCast
Oxford Biomedica partner delays Parkinson's dise... 30-Oct-2020 ShareCast
Oxford Biomedica new manufacturing suite approved 06-Oct-2020 ShareCast
Oxford Biomedica sees swing to FY profit on Covi... 17-Sep-2020 ShareCast
Oxford Biomedica slumps as AstraZeneca vaccine t... 09-Sep-2020 ShareCast
Oxford Biomedica, AstraZeneca extend Covid vacci... 01-Sep-2020 ShareCast
Oxford Biomedica signs deal with Beam Therapeutics 03-Aug-2020 ShareCast
Oxford Biomedica signs supply deal with Axovant ... 31-Jul-2020 ShareCast
AstraZeneca Covid-19 vaccine shows promise - rep... 15-Jul-2020 ShareCast
Oxford Biomedica signs deal with UK-backed vacci... 08-Jun-2020 ShareCast
Oxford Biomedica swings to loss as licensing rev... 06-May-2020 ShareCast
Liberum hikes target price on Oxford Biomedica 28-Apr-2020 ShareCast
Oxford Biomedica joins Covid-19 vaccine consortium 08-Apr-2020 ShareCast
Novo Holdings pours ?53.5m into Oxford Biomedica 28-May-2019 ShareCast
Friday broker round-up 15-Mar-2019 ShareCast
Oxford Biomedica swings to positive earnings in ... 14-Mar-2019 ShareCast
Oxford Biomedica enters research collaboration w... 12-Mar-2019 ShareCast
Oxford BioMedica forms new digital framework ini... 23-Nov-2018 ShareCast
First patient successfully dosed with Oxford Bio... 25-Oct-2018 ShareCast
'Transformative year' sees Oxford Biomedica prof... 13-Sep-2018 ShareCast
Oxford Biomedica could be in line for larger roy... 18-Jul-2018 ShareCast
Oxford BioDynamics' 'diagnostic potential' revea... 26-Jun-2018 ShareCast
Oxford Biomedica 'fully valued' as Jefferies ups... 13-Jun-2018 ShareCast
Wednesday broker round-up 13-Jun-2018 ShareCast
Sunday share tips: Oxford BioMedica, Avast, Sava... 10-Jun-2018 ShareCast
Oxford Biomedica inks licensing agreement with A... 06-Jun-2018 ShareCast
Oxford BioMedica reaps rewards of Novartis' FDA ... 02-May-2018 ShareCast
Oxford Biomedica announces placing to inject £20... 09-Mar-2018 ShareCast
Oxford BioMedica signs collaboration agreement w... 15-Feb-2018 ShareCast
Boost for Oxford Biomedica as Novartis files for... 31-Oct-2017 ShareCast
Sunday newspaper round-up: London Fisheries Conv... 02-Jul-2017 ShareCast
Oxford BioMedica's RetinoStat achieves 'favourab... 10-Oct-2016 ShareCast
Oxford Biomedica to raise £8.1m in placing 23-Feb-2016 ShareCast
Oxford Biomedica signs 'transformational' new co... 03-Nov-2014 ShareCast
Friday broker round-up UPDATE 10-Oct-2014 ShareCast
Friday broker round-up UPDATE 11-Apr-2014 ShareCast
Oxford BioMedica posts 12.1m pound loss 10-Apr-2014 ShareCast
Oxford BioMedica wins green light to resume clin... 17-Oct-2013 ShareCast
Directors at Thorntons top up as profits return 12-Sep-2013 ShareCast
Thursday broker round-up UPDATE 12-Sep-2013 ShareCast
Oxford Biomedica wins significant government fun... 11-Sep-2013 ShareCast
Oxford BioMedica receives million dollar milesto... 28-Aug-2013 ShareCast
Qualye Munro director buys 3.3 per cent stake ah... 16-Jul-2013 ShareCast
Signet CFO sells amid share-price strength 20-Jun-2013 ShareCast
Oxford Instruments lifts annual profit 11-Jun-2013 ShareCast
Oxford Biomedica Chief Scientific Officer steps ... 06-Jun-2013 ShareCast
Oxford Biomedica slumps as clinical trial is put... 03-Jun-2013 ShareCast
Monday broker round-up UPDATE 03-Jun-2013 ShareCast

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 245.00p
Change Today 16.50p
% Change 7.22 %
52 Week High 470.00p
52 Week Low 166.80p
Volume 189,306
Shares Issued 100.00m
Market Cap £245.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.41% above the market average32.41% above the market average32.41% above the market average32.41% above the market average32.41% above the market average
84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average84.31% above the sector average
Price Trend
50.63% below the market average50.63% below the market average50.63% below the market average50.63% below the market average50.63% below the market average
28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average28.57% above the sector average
Income Not Available
Growth
6.24% above the market average6.24% above the market average6.24% above the market average6.24% above the market average6.24% above the market average
38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average38.89% above the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 29-Apr-2024

Time Volume / Share Price
10:22 2,617 @ 245.00p
10:22 410 @ 245.00p
10:22 2,660 @ 245.00p
10:22 340 @ 245.00p
10:22 460 @ 244.50p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page